Health benefits of fucoxanthin in the prevention of chronic diseases

被引:163
作者
Bae, Minkyung [1 ]
Kim, Mi-Bo [1 ]
Park, Young-Ki [1 ]
Lee, Ji-Young [1 ,2 ]
机构
[1] Univ Connecticut, Dept Nutr Sci, Storrs, CT 06269 USA
[2] Kyung Hee Univ, Dept Food & Nutr, Seoul, South Korea
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2020年 / 1865卷 / 11期
关键词
Fucoxanthin; Carotenoid; Brown seaweed; Antioxidant; Anti-inflammation; INDUCED OXIDATIVE STRESS; DIET-INDUCED OBESITY; FATTY LIVER-DISEASE; DOWN-REGULATION; SINGLET OXYGEN; ADIPOSE-TISSUE; METABOLITE FUCOXANTHINOL; CAROTENOID FUCOXANTHIN; PI3K/AKT/MTOR PATHWAY; INDUCED INFLAMMATION;
D O I
10.1016/j.bbalip.2020.158618
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Fucoxanthin is a xanthophyll carotenoid abundant in macroalgae, such as brown seaweeds. When fucoxanthin is consumed, it can be esterified or hydrolyzed to fucoxanthinol in the gastrointestinal tract and further converted into amarouciaxanthin A in the liver. It has a unique chemical structure that confers its biological effects. Fucoxanthin has a strong antioxidant capacity by scavenging singlet molecular oxygen and free radicals. Also, it exerts an anti-inflammatory effect. Studies have demonstrated potential health benefits of fucoxanthin for the prevention of chronic diseases, such as cancer, obesity, diabetes mellitus, and liver disease. Animal studies have shown that fucoxanthin supplementation has no adverse effects. However, investigation of the safety of fucoxanthin consumption in humans is lacking. Clinical trials are required to assess the safety of fucoxanthin in conjunction with the study of mechanisms by which fucoxanthin exhibits its health benefits. This review focuses on current knowledge of metabolism and functions of fucoxanthin with its potential health benefits. This article is part of a Special Issue entitled Carotenoids recent advances in cell and molecular biology edited by Johannes von Lintig and Loredana Quadro.
引用
收藏
页数:7
相关论文
共 92 条
[1]
The effects of Xanthigen™ in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat [J].
Abidov, M. ;
Ramazanov, Z. ;
Seifulla, R. ;
Grachev, S. .
DIABETES OBESITY & METABOLISM, 2010, 12 (01) :72-81
[2]
Isolation of allene carotenoids from mamey [J].
Agocs, Attila ;
Murillo, Enrique ;
Turcsi, Erika ;
Beni, Szabolcs ;
Darcsi, Andras ;
Szappanos, Adam ;
Kurtan, Tibor ;
Deli, Jozsef .
JOURNAL OF FOOD COMPOSITION AND ANALYSIS, 2018, 65 :1-5
[3]
[Anonymous], 2018, SIGGR ACM SIGGR, DOI DOI 10.1145/3214745.3214758
[4]
[Anonymous], 2017, MARINE DRUGS, DOI DOI 10.3390/MD15020039
[5]
[Anonymous], 2019, NUTRIENTS, DOI DOI 10.3390/NU11040796
[6]
Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: Formation and cytotoxicity of fucoxanthin metabolites [J].
Asai, A ;
Sugawara, T ;
Ono, H ;
Nagao, A .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (02) :205-211
[7]
Low bioavailability of dietary epoxyxanthophylls in humans [J].
Asai, Akira ;
Yonekura, Lina ;
Nagao, Akihiko .
BRITISH JOURNAL OF NUTRITION, 2008, 100 (02) :273-277
[8]
Down-Regulation of Hepatic Stearoyl-CoA Desaturase-1 Expression by Fucoxanthin via Leptin Signaling in Diabetic/Obese KK-A y Mice [J].
Beppu, Fumiaki ;
Hosokawa, Masashi ;
Yim, Mi-Jin ;
Shinoda, Taro ;
Miyashita, Kazuo .
LIPIDS, 2013, 48 (05) :449-455
[9]
Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice [J].
Beppu, Fumiaki ;
Niwano, Yoshimi ;
Tsukui, Takayuki ;
Hosokawa, Masashi ;
Miyashita, Kazuo .
JOURNAL OF TOXICOLOGICAL SCIENCES, 2009, 34 (05) :501-510
[10]
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]